BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kasztura M, Richard A, Bempong NE, Loncar D, Flahault A. Cost-effectiveness of precision medicine: a scoping review. Int J Public Health 2019;64:1261-71. [PMID: 31650223 DOI: 10.1007/s00038-019-01298-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Serelli-lee V, Ito K, Koibuchi A, Tanigawa T, Ueno T, Matsushima N, Imai Y. A State-of-the-Art Roadmap for Biomarker-Driven Drug Development in the Era of Personalized Therapies. JPM 2022;12:669. [DOI: 10.3390/jpm12050669] [Reference Citation Analysis]
2 Hamamoto R, Komatsu M, Takasawa K, Asada K, Kaneko S. Epigenetics Analysis and Integrated Analysis of Multiomics Data, Including Epigenetic Data, Using Artificial Intelligence in the Era of Precision Medicine. Biomolecules. 2019;10:62. [PMID: 31905969 DOI: 10.3390/biom10010062] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 7.3] [Reference Citation Analysis]
3 McMichael AJ, Kane JPM, Rolison JJ, O'Neill FA, Boeri M, Kee F. Implementation of personalised medicine policies in mental healthcare: results from a stated preference study in the UK. BJPsych Open 2022;8:e40. [PMID: 35109949 DOI: 10.1192/bjo.2022.9] [Reference Citation Analysis]
4 Clasen K, Gani C, Schroeder C, Riess O, Zips D, Schöffski O, Clasen S. The patients view on genetics and functional imaging for precision medicine: a willingness-to-pay analysis. Per Med 2022. [PMID: 34984920 DOI: 10.2217/pme-2021-0067] [Reference Citation Analysis]
5 Stenzinger A, Edsjö A, Ploeger C, Friedman M, Fröhling S, Wirta V, Seufferlein T, Botling J, Duyster J, Akhras M, Thimme R, Fioretos T, Bitzer M, Cavelier L, Schirmacher P, Malek N, Rosenquist R; GMS working groups and ZPM working groups. Trailblazing precision medicine in Europe: A joint view by Genomic Medicine Sweden and the Centers for Personalized Medicine, ZPM, in Germany. Semin Cancer Biol 2021:S1044-579X(21)00156-5. [PMID: 34033893 DOI: 10.1016/j.semcancer.2021.05.026] [Reference Citation Analysis]
6 Sirdah MM, Reading NS. Genetic predisposition in type 2 diabetes: A promising approach toward a personalized management of diabetes. Clin Genet 2020;98:525-47. [PMID: 32385895 DOI: 10.1111/cge.13772] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
7 Jiang S. Transition and innovation ecosystem – investigating technologies, focal actors, and institution in eHealth innovations. Technological Forecasting and Social Change 2022;175:121369. [DOI: 10.1016/j.techfore.2021.121369] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Levit SL, Tang C. Polymeric Nanoparticle Delivery of Combination Therapy with Synergistic Effects in Ovarian Cancer. Nanomaterials (Basel) 2021;11:1048. [PMID: 33923947 DOI: 10.3390/nano11041048] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Feenstra T, Corro-Ramos I, Hamerlijnck D, van Voorn G, Ghabri S. Four Aspects Affecting Health Economic Decision Models and Their Validation. Pharmacoeconomics 2021. [PMID: 34913142 DOI: 10.1007/s40273-021-01110-w] [Reference Citation Analysis]
10 Fagherazzi G. Deep Digital Phenotyping and Digital Twins for Precision Health: Time to Dig Deeper. J Med Internet Res 2020;22:e16770. [PMID: 32130138 DOI: 10.2196/16770] [Cited by in Crossref: 13] [Cited by in F6Publishing: 6] [Article Influence: 6.5] [Reference Citation Analysis]
11 Shields GE, Pennington B, Bullement A, Wright S, Elvidge J. Out of Date or Best Before? A Commentary on the Relevance of Economic Evaluations Over Time. Pharmacoeconomics 2021. [PMID: 34866171 DOI: 10.1007/s40273-021-01116-4] [Reference Citation Analysis]
12 Fonseca L. Medicina personalizada en urología: Perspectiva desde un sistema de salud con escasez. Revista Urología Colombiana / Colombian Urology Journal 2022;31:e1-2. [DOI: 10.1055/s-0042-1745725] [Reference Citation Analysis]
13 Chen QY, Zhong Q, Li P, Xie JW, Liu ZY, Huang XB, Lin GT, Wang JB, Lin JX, Lu J, Cao LL, Lin M, Zheng QL, Tu RH, Huang ZN, Zheng CH, Huang CM. Comparison of submucosal and subserosal approaches toward optimized indocyanine green tracer-guided laparoscopic lymphadenectomy for patients with gastric cancer (FUGES-019): a randomized controlled trial. BMC Med 2021;19:276. [PMID: 34702260 DOI: 10.1186/s12916-021-02125-y] [Reference Citation Analysis]
14 Erdmann A, Rehmann-Sutter C, Bozzaro C. Patients' and professionals' views related to ethical issues in precision medicine: a mixed research synthesis. BMC Med Ethics 2021;22:116. [PMID: 34465328 DOI: 10.1186/s12910-021-00682-8] [Reference Citation Analysis]